pharmaphorum November 19, 2024
Nicole Raleigh

Since the results of the US election, the news has been awash with what the future might hold under a second Trump Administration, particularly within healthcare and life sciences.

In today’s podcast, web editor Nicole Raleigh is joined by Jesse Mendelsohn, senior vice president of Model N’s Center of Excellence, for a conversation that explores multiple aspects of the drug pricing debate in America – speaking before President-Elect Donald Trump confirmed his nomination of Robert F Kennedy Jr as US Health and Human Services Secretary.

Mendelsohn – using...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Congress / White House, Govt Agencies, Trends
What will happen in healthcare following the election? Hear from our experts.
5 legislative updates for GIs to watch
Demand for birth control, abortion pills skyrocket post-election
Future of Medicare drug price negotiations under new administration: 5 things to know
5 Cybersecurity Priorities for The Trump Administration

Share This Article